Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
BrainsWay Ltd is a commercial-stage medical device company focused on advancing neuroscience to improve health and transform lives. It is engaged in the development and commercialization of noninvasive neurostimulation products using its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD), obsessive-compulsive disorder (OCD), and smoking addiction. It derives revenues from the lease and sale of Deep TMS systems.
Jerusalem, 9777518, Israel